Literature DB >> 17072654

Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database.

Antonino Lauria1, Mario Ippolito, Anna Maria Almerico.   

Abstract

Topoisomerase I (Top1) is an essential enzyme participating to all those processes associated with separation of DNA strands. It manages superhelical tensions through the transient breakage of one strand of duplex DNA, followed by the unwinding of supercoiled DNA. Camptothecins, a class of alkaloids extracted from the wood of a Chinese tree, were found to be potent inhibitors of Topoisomerase I. The National Cancer Institute (NCI) Anti-cancer Agents Mechanism Database contains several camptothecins derivatives, classified as selective Top1 inhibitors. In this work we performed molecular docking studies on 24 camptothecin-like inhibitors present in this database (using Autodock 3.0.5). In order to consider the different orientations of the active site residues, docking was performed using four different structures of a Top1-DNA complex. The results obtained allowed us to analyze some conformations adopted by the inhibitors during active site binding, confirming the role of hydrogen bond and contributed to clarify the loss of activity due to single point mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072654     DOI: 10.1007/s00894-006-0159-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  18 in total

1.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

2.  Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis.

Authors:  X G Li; P Haluska; Y H Hsiang; A K Bharti; D W Kufe; L F Liu; E H Rubin
Journal:  Biochem Pharmacol       Date:  1997-04-04       Impact factor: 5.858

3.  Breakage of single-stranded DNA by eukaryotic type 1 topoisomerase occurs only at regions with the potential for base-pairing.

Authors:  M D Been; J J Champoux
Journal:  J Mol Biol       Date:  1984-12-15       Impact factor: 5.469

4.  Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.

Authors:  Bart L Staker; Michael D Feese; Mark Cushman; Yves Pommier; David Zembower; Lance Stewart; Alex B Burgin
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

5.  Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex.

Authors:  X Wang; X Zhou; S M Hecht
Journal:  Biochemistry       Date:  1999-04-06       Impact factor: 3.162

6.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

Authors:  R P Hertzberg; M J Caranfa; K G Holden; D R Jakas; G Gallagher; M R Mattern; S M Mong; J O Bartus; R K Johnson; W D Kingsbury
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

7.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

Review 8.  Camptothecin: current perspectives.

Authors:  Craig J Thomas; Nicolas J Rahier; Sidney M Hecht
Journal:  Bioorg Med Chem       Date:  2004-04-01       Impact factor: 3.641

9.  The domain organization of human topoisomerase I.

Authors:  L Stewart; G C Ireton; J J Champoux
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

10.  Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.

Authors:  Y Fan; J N Weinstein; K W Kohn; L M Shi; Y Pommier
Journal:  J Med Chem       Date:  1998-06-18       Impact factor: 7.446

View more
  4 in total

1.  Quinoline alkaloids as intercalative topoisomerase inhibitors.

Authors:  Kendall G Byler; Chen Wang; William N Setzer
Journal:  J Mol Model       Date:  2009-05-08       Impact factor: 1.810

2.  Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.

Authors:  Fung-Ming Siu; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2013-09-09       Impact factor: 16.971

3.  Diterpenoids from Roots of Salvia lachnocalyx; In-silico and In-vitro Toxicity against Human Cancer Cell Lines.

Authors:  Hossein Hadavand Mirzaei; Omidreza Firuzi; Amir Reza Jassbi
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

4.  Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study.

Authors:  Jingli Liu; Hui Guo; Jing Zhou; Yuwei Wang; Hao Yan; Ruyi Jin; Yuping Tang
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.